Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV capsid protein, also known as CA or p24, is a major structural component of HIV-1. It forms the conical capsid core that protects the viral RNA genome. Essential for multiple steps in the viral life cycle including assembly, maturation, uncoating, nuclear import and integration. It interacts with numerous host cell factors which influences viral infectivity and sensitivity to antiviral drugs, making it a key target for drug development.
Inhibition of capsid assembly/disassembly, binding to capsid protein and interfering with its function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV Capsid Protein (CA).